Dr Reddy Launches Anti-Cancer Injection in US

Dr. Reddy\’s Laboratories Ltd, a pharmaceutical company based in Hyderabad, Telangana, India recently launched DOCETAXEL Injection USP 20 mg/ml and 80 mg/ 4ml a generic version of TAXOTERE in the US market. The market value of the drug is worth $218 billion in the US Market. Taxotere (docetaxel) is a cancer medication that interferes with …

Dr Reddy Launches Anti-Cancer Injection in US Read More »